IJIP publishes original research, systematic reviews, implementation studies, outbreak reports, and data resources that advance infection prevention and control. Submissions should demonstrate rigorous methods, clear case definitions, and measurable prevention relevance.

• Title page with author names, affiliations, and corresponding author details
• Structured abstract with objectives, methods, results, and conclusions
• Introduction that defines the IPC context and research gap
• Methods with study design, case definitions, and surveillance protocols
• Results with validated outcomes, effect sizes, and confidence intervals
• Discussion linking findings to prevention practice or policy
• Conclusion highlighting key contributions and future directions

• Use clear headings and consistent terminology
• Define abbreviations and pathogen codes at first use
• Provide units and denominators for rates and metrics
• Include figure legends that describe sample sizes and data sources
• Prepare tables in editable format with clear headings
• Label supplementary files clearly and reference them in the text

• Provide ethics approvals and consent or waiver statements
• Follow CONSORT for trials and STROBE for observational studies
• Use PRISMA for systematic reviews and ORION or SQUIRE when applicable
• Disclose conflicts of interest and funding sources
• Describe limitations and generalizability

Authors should provide data availability statements and, when possible, deposit data in trusted repositories. Code or analysis pipelines should be shared or documented to support reproducibility.

• Include accession numbers or repository links
• Describe preprocessing and quality control steps
• Document software versions and computational environments
• State any access restrictions for sensitive data

• Submit high resolution figures in standard formats
• Label axes and include units for quantitative plots
• Provide color blind friendly palettes when possible
• Ensure tables are editable and include footnotes

• Ensure references are complete and consistent
• Include DOIs where available
• Use standard citation formats
• Confirm all in text citations appear in the reference list

Trials and outbreak evaluations should include registration identifiers when applicable and follow regulatory requirements. Observational studies using registries should describe data governance and consent limitations.

• Provide trial registration numbers when applicable
• Describe primary and secondary endpoints
• Report adverse events and safety monitoring
• Include protocol deviations and amendments

IJIP uses single blind peer review. Reviewers evaluate study rigor, data quality, and clarity of reporting. Initial decisions are typically issued within two to four weeks depending on reviewer availability.

Accepted manuscripts move to production for copyediting, proof review, and DOI registration. Articles are published under CC BY 4.0 to support open access reuse with attribution.

Authors should review proofs promptly to confirm accuracy of figures, tables, and metadata.

APCs are applied after acceptance and cover peer review management, production, and archiving services. Partial waivers may be available for eligible authors. Contact the editorial office for guidance.

• Scope alignment confirmed
• Data availability statement included
• Case definitions and denominators documented
• Cover letter prepared with scope summary
• Ethics and consent statements included

For questions about formatting or submission steps, contact [email protected].

• Report case definitions and diagnostic criteria used for infections.
• Provide surveillance setting details, including unit type and population served.
• Define denominators for incidence rates, device days, or patient days.
• Describe infection control bundles or interventions implemented.
• Report hand hygiene measurement methods and compliance rates.
• Include antimicrobial stewardship components and audit feedback processes.
• Describe PPE protocols, training, and adherence monitoring.
• Report environmental cleaning procedures and verification methods.
• Detail sterilization and disinfection standards followed.
• Include outbreak investigation timelines and trigger thresholds.
• Report contact tracing or exposure assessment approaches when relevant.
• Describe vaccination coverage, uptake, and hesitancy metrics.
• Provide genomic surveillance methods and sequence repository links.
• Include antibiotic resistance profiles and antibiogram methodology.
• Report risk adjustment variables used in comparative analyses.
• Describe infection prevention staffing models and training programs.
• Report WASH infrastructure context for community settings.
• Include ventilation or air quality standards where applicable.
• Describe patient isolation practices and cohorting strategies.
• Report compliance audits and quality improvement cycles.
• Define outbreak control measures and escalation criteria.
• Provide health equity considerations and vulnerable population impacts.
• Include intervention fidelity monitoring and implementation barriers.
• Report data completeness checks and missing data handling.
• Describe ethical approvals and data privacy safeguards.
• Provide data availability statements and access conditions.
• State whether the study used WHO or CDC IPC guidelines.
• Describe training materials or behavior change tools used.
• Report costs, resource needs, or cost effectiveness where relevant.
• Include communication plans for outbreaks or public advisories.
• Describe interdisciplinary collaboration with laboratory teams.
• Provide primary and secondary outcome definitions.
• Report follow up durations and monitoring intervals.
• Include adverse event reporting for interventions.
• Describe pathogen transmission routes addressed by the study.
• Report screening or admission testing protocols.
• Clarify definitions for community versus healthcare associated infections.
• Include evidence of sustainability or long term adherence.
• Provide staffing or workload metrics that influence IPC outcomes.
• Describe cluster detection methods and alert thresholds used in surveillance.
• Report antimicrobial consumption metrics such as DDD per 1,000 patient days.
• Define contact precautions and isolation duration criteria applied.
• Include ventilation or air filtration parameters relevant to transmission control.
• Document environmental cleaning audits and verification tools used.
• Report staff vaccination rates or screening compliance where applicable.
• Describe patient education or signage used to reinforce IPC behaviors.
• Include outbreak communication workflows and escalation pathways.
• Report baseline infection trends and comparison periods.
• Describe PPE supply chain or access constraints that influenced implementation.
• Include adherence to WHO 5 Moments or equivalent hand hygiene standards.
• State whether isolation practices were supported by cohorting or dedicated staffing.
• Describe audit feedback loops and how findings were actioned.
• Report sustainability plans for IPC interventions beyond the study period.
• Clarify alignment with national IPC guidelines or regulatory standards.
• Provide a structured abstract with clear objectives, methods, results, and conclusions.
• Use consistent infection prevention terminology and define abbreviations at first use.
• Include a data availability statement with repository links or accession numbers.
• Report statistical tests, effect sizes, and confidence intervals where applicable.
• Describe study setting, population, and infection prevention context.
• Provide clear figure legends and indicate sample sizes and data sources.
• Confirm references include DOIs where available and match in text citations.
• Disclose funding sources, grant numbers, and potential conflicts of interest.
• Report ethical approvals and consent requirements.
• Include a brief limitations statement that addresses generalizability.
• State whether preprints exist and disclose prior dissemination.
• Describe how raw data and code can be accessed, including access controls.
• Provide outbreak reporting standards or registry identifiers when applicable.
• Include laboratory reference ranges and case classification criteria.
• Describe adverse event reporting and safety monitoring procedures.
• Clarify primary and secondary outcome definitions and timing.

IJIP is committed to rigorous, transparent publishing in infection prevention and control. We emphasize reproducible surveillance methods, clear reporting of case definitions, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in infection prevention science and implementation.